Parimifasor
Parimifasor (LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD) .
Product Specifications
CAS Number
1796641-10-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
460.214
Molecular Formula
C18H11Cl2F4N5O
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7097951 Inquire
Recombinant Avahi laniger NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial
Sign In for Pricing
View Details 